Chargement en cours...
MicroRNA‐379 suppresses osteosarcoma progression by targeting PDK1
Osteosarcoma is the most common primary bone tumour. Increasing evidence has demonstrated the pathogenic role of microRNA (miRNAs) dysregulation in tumour development. miR‐379 was previously reported to function as an oncogenic or tumour‐suppressing miRNA in a tissue‐dependent manner. However, its f...
Enregistré dans:
| Publié dans: | J Cell Mol Med |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5264134/ https://ncbi.nlm.nih.gov/pubmed/27781416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12966 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|